Although a recent observational study35 emulated some of the results of the GRADE (Glycemia Reduction Approaches In Diabetes: A Comparative Effectiveness Study) randomised trial,29, 36, 37 neither the trial nor the observational study considered SGLT-2 inhibitors, which limits the applicability of the results to routine clinical practice. This evidence concerns the gene SLC5A2 and diabetes mellitus.